Elevated serum levels of PAPP-A correlate with markers of early atherosclerosis, making it a potential biomarker for detecting subclinical atherosclerosis in asymptomatic patients, aiding in early intervention and improved prognosis. This evidence concerns the gene PAPPA and atherosclerosis.